Holen Sie sich die Stockscreener-App
13.91
0.43%
-0.08
Schlusskurs vom Vortag:
$13.99
Offen:
$13.97
24-Stunden-Volumen:
26,781
Relative Volume:
0.25
Marktkapitalisierung:
$362.91M
Einnahmen:
$59,000
Nettoeinkommen (Verlust:
$-21.81M
KGV:
-1.2701
EPS:
-10.9518
Netto-Cashflow:
$-18.07M
1W Leistung:
+0.58%
1M Leistung:
+10.91%
6M Leistung:
-11.05%
1J Leistung:
+61.51%
1-Tages-Spanne:
$13.65
$13.97
1-Wochen-Bereich:
$13.49
$14.15
52-Wochen-Spanne:
$8.20
$17.15
Benitec Biopharma Inc Stock (BNTC) Company Profile
Firmenname
Benitec Biopharma Inc
Sektor
Branche
Telefon
(510) 780-0819
Adresse
3940 TRUST WAY, HAYWARD, CA
Vergleichen Sie BNTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
13.82 | 367.24M | 59,000 | -21.81M | -18.07M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
386.03 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
595.45 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.04 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
728.26 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.44 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Eingeleitet | TD Cowen | Buy |
| 2024-12-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-13 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-10-16 | Eingeleitet | Oppenheimer | Outperform |
| 2024-09-12 | Eingeleitet | Guggenheim | Buy |
| 2024-07-22 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-13 | Eingeleitet | Piper Sandler | Overweight |
| 2020-10-05 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-04-20 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2016-02-26 | Herabstufung | Maxim Group | Buy → Hold |
| 2015-12-31 | Bestätigt | Maxim Group | Buy |
| 2015-09-16 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Benitec Biopharma Inc Aktie (BNTC) Neueste Nachrichten
Aug EndMonth: Is Benitec Biopharma Inc attractive at current valuationWeekly Profit Recap & Consistent Profit Alerts - khodrobank.com
How to build a custom watchlist for Benitec Biopharma Inc.Share Buyback & Free Expert Approved Momentum Trade Ideas - newser.com
Retail Trends: Whats KVACs historical returnExit Point & Trade Opportunity Analysis - خودرو بانک
Is Benitec Biopharma Inc. stock bottoming outMarket Rally & Expert-Curated Trade Recommendations - newser.com
Visual analytics tools that track Benitec Biopharma Inc. performanceGDP Growth & Step-by-Step Trade Execution Guides - newser.com
Will Benitec Biopharma Inc. benefit from macro trends2025 Trading Volume Trends & Accurate Entry/Exit Alerts - newser.com
Benitec Biopharma (BNTC) Expected to Announce Quarterly Earnings on Thursday - Defense World
How to manage a losing position in Benitec Biopharma Inc.Quarterly Market Summary & Verified Momentum Stock Alerts - newser.com
Layoff Watch: What is Momentus Inc.’s valuation compared to sectorEarnings Beat & Verified Chart Pattern Signals - خودرو بانک
Will Benitec Biopharma Inc. price bounce be sustainableTrade Volume Summary & Free Fast Entry Momentum Trade Alerts - newser.com
Inflation Data: Is Benitec Biopharma Inc. stock a top performer YTDGlobal Markets & AI Driven Stock Reports - khodrobank.com
Can machine learning forecast Benitec Biopharma Inc. recoveryWeekly Risk Summary & Weekly Market Pulse Alerts - newser.com
Stock Recap: Is Benitec Biopharma Inc forming a double bottomJuly 2025 Institutional & Reliable Price Breakout Alerts - khodrobank.com
Chipmakers Recap: Should I buy Benitec Biopharma Inc. stock nowWeekly Investment Report & Fast Gaining Stock Strategy Reports - خودرو بانک
BNTC: Oppenheimer Lowers Price Target While Maintaining Outperfo - GuruFocus
Is Benitec Biopharma Inc. stock reversal real or fake2025 Key Highlights & Detailed Earnings Play Strategies - newser.com
Market Review: Can Benitec Biopharma Inc maintain its current growth rate2025 Macro Impact & Risk Controlled Daily Trade Plans - khodrobank.com
Oppenheimer Adjusts Benitec Biopharma PT to $29 From $35, Maintains Outperform Rating - MarketScreener
Does Benitec Biopharma Inc. show high probability of reboundPortfolio Return Summary & Expert Approved Trade Ideas - newser.com
Analysis Recap: Is Benitec Biopharma Inc stock a buy or sell2025 Pullback Review & Low Risk High Win Rate Picks - khodrobank.com
Is a relief rally coming for Benitec Biopharma Inc. holdersDollar Strength & Low Drawdown Momentum Trade Ideas - newser.com
Intraday pattern recognizer results for Benitec Biopharma Inc.2025 Historical Comparison & AI Based Buy and Sell Signals - newser.com
Chart overlay techniques for tracking Benitec Biopharma Inc.July 2025 Analyst Calls & Daily Technical Forecast Reports - newser.com
Trade Report: What is the PEG ratio of Benitec Biopharma Inc2025 Winners & Losers & High Conviction Buy Zone Alerts - khodrobank.com
Will Benitec Biopharma Inc. see short term momentumSwing Trade & Advanced Technical Analysis Signals - newser.com
Real time alert setup for Benitec Biopharma Inc. performanceWall Street Watch & Safe Swing Trade Setups - newser.com
Activity Recap: Is Benitec Biopharma Inc. attractive at current valuationEarnings Performance Report & Smart Swing Trading Alerts - khodrobank.com
Aug Sentiment: Is Benitec Biopharma Inc forming a breakout patternTrade Risk Assessment & Verified Momentum Stock Watchlist - khodrobank.com
Will earnings trigger a reversal in Benitec Biopharma Inc.Wall Street Watch & Expert Verified Stock Movement Alerts - newser.com
Applying sector rotation models to Benitec Biopharma Inc.2025 Top Gainers & High Yield Stock Recommendations - newser.com
can machine learning forecast benitec biopharma inc. recoveryRate Cut & Consistent Growth Stock Picks - newser.com
Finanzdaten der Benitec Biopharma Inc-Aktie (BNTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Benitec Biopharma Inc-Aktie (BNTC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Mar 26 '25 |
Buy |
13.00 |
900,000 |
11,700,000 |
8,793,245 |
| BUCHI J KEVIN | Director |
Feb 27 '25 |
Option Exercise |
3.86 |
51,813 |
199,998 |
103,910 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 23 '24 |
Buy |
10.98 |
27,502 |
301,972 |
7,981,725 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 24 '24 |
Buy |
11.25 |
20,018 |
225,202 |
7,999,455 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 03 '24 |
Buy |
9.60 |
42,000 |
403,200 |
7,957,365 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 20 '24 |
Buy |
10.22 |
27,436 |
280,396 |
7,920,175 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 19 '24 |
Buy |
9.73 |
14,000 |
136,220 |
7,895,815 |
1.54%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):